Clinical Trial Update: Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain [NA]

View source ↗

Summary

Clinical trial update for Erchonia EVRL OTC intended to relieve diabetic peripheral neuropathy foot pain; the study is completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Neuropathy

Drugs mentioned

• Erchonia EVRL OTC

Snippet

Sponsor: Erchonia Corporation | Conditions: Neuropathy | NA | Status: COMPLETED | Results posted: 2022-06-06